Rituximab for the treatment of type II mixed cryoglobulinemia.

被引：0
|
作者：
Zaja, F
De Vita, S
Sperotto, A
Sacco, S
Mazzaro, C
Tomadini, V
Ferraccioli, G
Baccarani, M
Fanin, R
机构：
[1] DPMMR, Div Hematol, Udine, Italy
[2] DPMSC, Div Rheumatol, Udine, Italy
[3] SM Angeli Hosp, Pordenone, Italy
[4] Seragnoli Inst, Bologna, Italy
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3919
引用
收藏
页码：54B / 54B
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of rituximab treatment in Type II mixed cryoglobulinemia.
    De Vita, S
    Zaja, F
    Sacco, S
    Michelutti, A
    De Marchi, G
    Mazzaro, C
    Fanin, R
    Ferraccioli, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S206 - S206
  • [2] Response to rituximab in type II Cryoglobulinemia.
    Bryce, AH
    Dispenzieri, A
    Kyle, RA
    Lacy, M
    Rajkumar, SV
    Inwards, DJ
    Yasenchak, C
    Kumar, S
    Gertz, MA
    BLOOD, 2005, 106 (11) : 977A - 977A
  • [3] Rituximab for the treatment of type II mixed cryoglobulinemia
    Zaja, F
    Russo, D
    Fuga, G
    Patriarca, F
    Ermacora, A
    Baccarani, M
    HAEMATOLOGICA, 1999, 84 (12) : 1157 - 1158
  • [4] Rituximab: A novel treatment for type II mixed cryoglobulinemia
    De Vita, S
    Zaja, F
    De Marchi, G
    Damiani, D
    Sacco, S
    Mazzaro, C
    Fanin, R
    Ferraccioli, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 84 - 84
  • [5] Treatment of glomerulonephritis in type II mixed cryoglobulinemia with rituximab.
    Quartuccio, L
    Soardo, G
    Romano, G
    Sacco, S
    Esposito, W
    De Marchi, G
    De Vita, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S235 - S235
  • [6] The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia
    Goncalves Rego, Thiago Carlos
    Massumoto, Celso Mitsushi
    Batista, Rodrigo Siqueira
    de Moura, Larissa Hanauer
    Costa Soares, Lygia Maria
    Gomes, Andreia Patricia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01): : 174 - 175
  • [7] Mixed cryoglobulinemia. Essential?
    Ramos-Casals, M
    Font, J
    MEDICINA CLINICA, 1999, 113 (15): : 577 - 578
  • [8] Efficacy and safety of rituximab in type II mixed cryoglobulinemia
    Zaja, F
    De Vita, S
    Mazzaro, C
    Sacco, S
    Damiani, D
    De Marchi, G
    Michelutti, A
    Baccarani, M
    Fanin, R
    Ferraccioli, G
    BLOOD, 2003, 101 (10) : 3827 - 3834
  • [9] Rituximab in HCV-related mixed cryoglobulinemia. Report of 4 cases
    Migliaresi, S
    Ambrosone, L
    Colutta, E
    Cioffi, R
    Valentini, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 539 - 539
  • [10] Increased soluble TNF alpha receptors type I and type II in the serum of patients with mixed cryoglobulinemia.
    Cacoub, P
    Farnarier, C
    Kaplanski, G
    Musset, L
    Duraud, JM
    Gatel, A
    Lunel, F
    Soubeyrand, J
    Bongrand, P
    Godeau, P
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 720 - 720
12345